Though 24 states and thousands of local governments have agreed to a multibillion dollar settlement with Purdue Pharma, 25 states and the District of Columbia have not agreed, according to a survey from the Associated Press. The opposed states say the settlement doesn’t do enough to hold the Sacklers — the founding family behind Purdue Pharma and OxyContin — personally accountable and that they should pay more than what they’ve offered.
Purdue Pharma’s lawyers argue that allowing further litigation in other courts would take money away from the company’s creditors and be “fatal” to a comprehensive deal. They believe the Sackler family is entitled to a shield from further litigation, a move that would likely create a dispute in bankruptcy court, according to the WSJ.
More articles on opioids:
Historians request permanent, public archive of opioid litigation
AMA: 6 ways states can combat the opioid epidemic
Americans 7x more likely to fill opioid prescriptions than Swedes
